ImageNet classification with deep convolutional neural networks
Alex Krizhevsky, Ilya Sutskever et al.
2.5k
Citations
49
Influential Citations
Molecules
Venue
2015
Year
Pharmaceutical research has successfully incorporated a wealth of molecular modeling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process. Today, as a variety of docking algorithms are available, an understanding of the advantages and limitations of each method is of fundamental importance in the development of effective strategies and the generation of relevant results. The purpose of this review is to examine current molecular docking strategies used in drug discovery and medicinal chemistry, exploring the advances in the field and the role played by the integration of structure- and ligand-based methods.
This review paper is a cornerstone reference in the field of computational drug discovery, as evidenced by its high citation count (2492). It systematically catalogs and compares molecular docking strategies, which are essential for predicting how small molecules (ligands) interact with biological targets (receptors). For AI practitioners, the paper underscores the critical role of computational methods in reducing the cost and time of drug development, and it highlights the need for robust algorithms that can accurately model the complex physics of molecular recognition.
The paper matters because it bridges the gap between computational chemistry and practical drug design. By discussing both structure-based and ligand-based methods, it provides a holistic view that is valuable for researchers developing AI models for virtual screening, binding affinity prediction, and de novo drug design. The emphasis on understanding the limitations of each docking algorithm is particularly relevant for machine learning practitioners who often rely on docking scores as features or ground truth.
As a review paper, there are no novel experimental results or quantitative benchmarks. The paper's impact is measured by its citation count (2492) and its role as a reference for subsequent research. It does not report metrics like docking accuracy, enrichment factors, or AUC values for specific methods.
The broader impact of this paper lies in its educational value and its influence on the drug discovery community. It has helped standardize the vocabulary and conceptual framework for molecular docking, enabling more effective communication between computational chemists and experimental biologists. For AI researchers, the paper highlights the importance of domain knowledge in designing better models for drug-target interaction prediction. It also points to open challenges, such as handling protein flexibility and scoring function accuracy, which remain active areas of machine learning research.
Alex Krizhevsky, Ilya Sutskever et al.
Ashish Vaswani, Noam Shazeer et al.
Douglas M. Bates, Martin Mächler et al.
Diederik P. Kingma, Jimmy Ba